Cannabis

Monday Oct 17, 2022 - 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Drug Development Program Seeking to Provide Safe, Well-Tolerated, Effective Antihypertensive Medication Amid Continued Reports of Suboptimal Adherence to Existing Treatments

Lexaria Bioscience, a global innovator in drug delivery technology, has developed a potential treatment for hypertension using the company’s patented DehydraTECH(TM) platform, now shown in several human studies to reduce blood pressure and arterial stiffnessLexaria’s antihypertensive drug development program comes at a time when researchers are documenting poor control of hypertension among both men and women, partly due to suboptimal adherence to existing antihypertension medicationReasons…

Monday Oct 17, 2022 - 9:00 am

Changing Legal Landscape for Cannabis in Colombia and the U.S. Portends a New Era of Productivity for Flora Growth Corp. (NASDAQ: FLGC)

Colombia and the United States have both recently exhibited new openness to the possibility of decriminalizing adult recreational cannabis use through legislative changeCannabis supplier Flora Growth cultivates its product at a key Colombian farm and provides it to international markets, and may see additional opportunities arise as cannabis policies advance in the two countriesFlora Growth recently announced completion of its first shipments of high-CBD dried…

Thursday Oct 13, 2022 - 9:45 am

Lift&Co. Expo Cannabis Business Conference & Trade Show Releases Limited All-Access Presale Tickets for Vancouver 2023

Canada’s leading Cannabis Conference and Trade Show, Lift&Co. Expo, invites all members of the cannabis industry and community to its upcoming Vancouver event taking place January 12-14, 2023, at the Vancouver Convention Centre. For a limited time, Lift&Co. Expo is releasing a limited number of discounted Lift Cannabis Business Conference (“LCBC”) + Expo All-Access presale tickets for $350 (regularly priced at $599). Starting on day…

Thursday Oct 13, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Using Patented DehydraTECH(TM) Technology to Fight America’s Silent Killer – Hypertension

Three out of four adults living with hypertension do not have the condition under control, putting them at risk for other serious complicationsLexaria’s proposed therapy for hypertension is the highly efficient DehydraTECH-CBD, which has presented with no serious adverse side effects in test participantsDominated by the North American market, the global antihypertension drug market accounted for $22,557 million in 2018 and is expected to reach…

Tuesday Oct 11, 2022 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented DehydraTECH(TM) Technology Offering Solutions to Growing Hypertension Problem Worldwide

Hypertension affects nearly half of all adults in the United States – 47% or 116 million people, some of which are medication-resistantA recent study from the University of Toledo College of Medicine and Life Sciences concluded gut bacteria might be the cause of medication-resistant hypertension – as demonstrated in rats used to conduct the studyLexaria’s patented DehydraTECH(TM) technology offers a viable solution for hypertension drug…

Monday Oct 10, 2022 - 12:00 pm

REZYFi, Inc. Leverages Rapidly Growing Cannabis Industry, Offering Needed Mortgage and Lending Solutions

REZYFi is a specialized financing company in the U.S., originating, structuring, and investing in first mortgage loans and alternative structured financings secured by commercial real estate propertiesTarget markets include licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financingCurrently licensed in 36 states, with plans…

Monday Oct 10, 2022 - 11:15 am

Rosy Outlook for Global Cannabis Market Boosts Hopes for Flora Growth Corp. (NASDAQ: FLGC) as Supply Chain Expands

Cannabis grower and product maker Flora Growth is developing its own approach to riding troubling economic forces, boasting a 604 percent YOY increase in the H1 reporting period this yearMarket analysts predict the global cannabis market’s value will rise during the next five years at a CAGR of 24.3 percent to arrive at annual valuation of $82.3 billionFlora Growth is levying the potential of recent…

Friday Oct 07, 2022 - 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Working to Address Declining Antihypertensive Intensification and High Prescription Abandonment Rates, with DehydraTECH-CBD

Lexaria is a global innovator in drug delivery platforms developing DehydraTECH-CBD as a potential treatment for hypertensionA 2022 study documented a decline in the percentage of patients receiving appropriate treatment intensification over the last ten yearsThis decline has been attributed to, among other possible reasons, the side effects of antihypertensive drugsAt the same time, only 24% of adults with hypertension have the condition under control,…

Tuesday Oct 04, 2022 - 9:45 am

Sugarmade Inc. (SGMD) Positioning Itself in Space Seeing Growing Government Support

More than a dozen cannabis reform bills were passed by the California legislature during the summerGovernor Newsom signed 10 of the billsSGMD is focused on strengthening its presence in a variety of spaces, including cannabis As the California legislature ended its session last month, more than a dozen cannabis reform bills were approved and sent to Governor Gavin Newsom for his consideration (https://ibn.fm/TLbMU); ultimately, the…

Monday Oct 03, 2022 - 10:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Focusing on Multiple Mainstream Applications of Its Disruptive Patented DehydraTECH(TM) Technology

Lexaria is the drug delivery platform innovator behind the disruptive, patented DehydraTECH(TM) technologyDehydraTECH is designed to enhance the performance of fat-soluble active pharmaceutical ingredients (“APIs”), molecules, and drugs by increasing their bioavailabilityThrough animal and human studies, Lexaria has shown that DehydraTECH increases the bioavailability of antiviral drugs, CBD, oral nicotine and moreThe company is focusing on multiple mainstream applications of its technology that rerrcould address…

Friday Sep 30, 2022 - 10:30 am

Flora Growth Corp. (NASDAQ: FLGC) Strategic Acquisitions, Expanding Cannabis Exports Give Significant Boost to Company’s Revenue Streams

Flora Growth is a global cannabis cultivator, product builder, and supplier, experiencing continued growth thanks to strategic acquisitions and an expanding supply chain for marketing its brands in various countriesFlora announced its most recent acquisition in September — a deal to acquire the assets of the No Cap Hemp Co. brand in exchange for payment of 10 percent of the No Cap brand revenues up…

Friday Sep 30, 2022 - 9:45 am

Sugarmade Inc. (SGMD) Makes Strategic Advancements in Plan to Grow Presence in California Cannabis Space

SGMD inks MSA with California cannabis micro license holderAgreement “lays a foundation for a significantly expanded manufacturing and distribution infrastructure,” says CEOKey partnerships are essential pieces of Sugarmade’s focus on California cannabis space With the recent signing of a management services agreement (“MSA”) (https://ibn.fm/2KYof), Sugarmade (OTC: SGMD) is making key progress toward the goal of strengthening its position in the California cannabis space. SGMD signed…

Thursday Sep 29, 2022 - 11:30 am

NECANN The High Lifestyle Show Comes to Massachusetts

Date: October 7-9, 2022 The first of its kind Cannabis event ‘The High Lifestyle Show’ is finally being held in Massachusetts, on October 7-9, 2022 at the Regency Hotel (Boxborough, MA). The event is organized by NECANN, the leading cannabis event organizer on the East Coast. Being held in a sprawling plush resort hotel, the event will witness a huge gathering of brands, dispensaries, distributors,…

Thursday Sep 29, 2022 - 10:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Addressing Hypertensive Patients’ Concerns with DehydraTECH-CBD

Lexaria is a global innovator in drug delivery platforms whose lead technology is DehydraTECH(TM)Studies have shown that DehydraTECH increases the intestinal bioabsorption of bioactive compounds by as much as 27 times, hence resulting in greater bioavailability; pre-clinical and human studies have demonstrated that DehydraTECH-CBD enables absorption increases of between 100% and 500% The studies have also shown that DehydraTECH-CBD results in a rapid and sustained…

Wednesday Sep 28, 2022 - 9:45 am

Rising Mortgage Lender REZYFi, Inc. Weathering Difficult Economy with Plans for Nationwide Expansion, Cannabis Industry Lending in Coming Months

REZYFi, a Miami-based mortgage lender, servicing traditional and non-traditional loans, is expanding its operations as part of a strategy to weather recent interest rate-affected market challenges REZYFI’s two wholly owned subsidiaries, REZYFi Lending and ResMac Inc., work through a network of independent brokers and proprietary technology to service home owners as well as corporate clients REZYFi expects to grow from more than 30 states where…

Monday Sep 26, 2022 - 12:00 pm

The 420 Expo, NJ’s First BYOC Public Event, Sparks High Attendance, Open Conversations & Awesome Vibe

Approximately 17,000 People Came Through the Doors of the Inaugural Event in Edison, NJ The 420 Expo, New Jersey’s first-ever BYOC Consumer Cannabis Convention, was an unmitigated success for the cannabis community, exceeding all expectations. Approximately 17,000 people aged 21+ attended the historic three-day event, from September 16-18, 2022, at the NJ Convention & Expo Center in Edison, NJ. Hosted by the legendary Tommy Chong…

Wednesday Sep 21, 2022 - 12:45 pm

Flora Growth Corp. (NASDAQ: FLGC) 7x YOY Revenue Growth for H1 2022 Affirms Hyper Growth

H1 2022 revenue increased to ~$15.0 million, up 604% from H1 2021 and 117% from H2 2021, driven by House of BrandsGross Profit increased to ~$7.0 million, up 547% compared to H1 2021 and 363% compared to H2 2021Company reaffirms its 2022 revenue guidance to range between $35.0 million - $45.0 million, indicating approximately 300% - 400% projected revenue growth from 2021 In August, Flora…

Wednesday Sep 21, 2022 - 12:00 pm

REZYFi Inc. Addresses Loan Needs of Growing Cannabis Industry Through Subsidiary Companies: REZYFi Lending and ResMac Inc.

The global cannabis market is expected to reach $33 billion by 2025, driven by legality and regulation within the marketREZYFi is servicing the needs of both traditional and non-traditional consumers and businessesCompany targets licensed and permitted cannabis companies, owners of real estate who lease to cannabis companies, and companies and individual homeowners seeking a variety of real estate-related first and additional mortgage-based financingREZYFi’s management team…

Wednesday Sep 21, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Looking to Provide Bioavailable Oral Treatment for Hypertension, Mitigate Effects of High Blood Pressure

Lexaria is a biotechnology company pursuing the enhancement of the bioavailability of a diverse and broad range of active pharmaceutical ingredients (“APIs”)The company has developed the patented DehydraTECH(TM) drug delivery technology, which has been shown to deliver more API at a faster rate than controlsLexaria’s DehydraTECH pipeline includes DehydraTECH-CBD for the treatment of hypertensionThrough pre-clinical studies, DehydraTECH-CBD has been shown to decrease systolic blood pressure…

Tuesday Sep 20, 2022 - 12:45 pm

Flora Growth Corp. (NASDAQ: FLGC) Agreement with Colombian Tribe Strengthens Cannabis Production Supply Chain

Flora Growth is a global cannabis brand-builder focused on the cultivation of product at a central Colombian facility and marketing through a design-led international supply chainFlora recently announced an agreement with Colombia’s Misak tribe for cooperative processing and distribution of cannabis, drawing on the tribe’s licensing advantage to accelerate the pair’s marketing capacityFlora is headquartered in Canada, but its strength lies in its Colombian-based cultivation…

Friday Sep 16, 2022 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX), Growing its Market Share, One Patent at a Time

Lexaria’s development of its patented DehydraTECH(TM) technology since 2014 has yielded 27 patents in Australia, the United States, the European Union, Japan, India and Mexico with approximately 50 additional patents pending around the worldIts latest patent, granted in Mexico, applies a range of active ingredients, including but not limited to non-psychoactive cannabinoids and NSAIDs in a variety of ready-to-drink consumer retail beverage productsLexaria remains committed…

Wednesday Sep 14, 2022 - 11:00 am

American Cannabis Partners Committed to Implementing Key Sustainable Operating Practices

Forbes reports that “sustainability is increasingly becoming a necessity for corporations due to changing perspectives around the world”Unfortunately, while 90% of executives think sustainability is important, only 60% of companies have a sustainability strategyACP’s sustainable operating practices appear ideally aligned with today’s expectations With a focus on sustainability becoming increasingly essential for companies to succeed in today’s market, American Cannabis Partners (“ACP”) has made its sustainable…

Wednesday Sep 14, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Strengthens Board of Directors to Boost Efforts toward Regulatory Approval of Potential Treatment for Hypertension

Lexaria Bioscience is a global innovator in drug delivery platforms whose lead technology, DehydraTECH, has been shown to increase the bioavailability of APIsThe company recently announced that Catherine Turkel, PharmD, Ph.D., has joined its board of directorsDr. Turkel, who brings over 20 years’ experience, has previously formulated Food and Drug Administration (“FDA”) registration and commercial strategic plans, as well as led global development programs for…

Tuesday Sep 13, 2022 - 12:00 pm

REZYFi, Inc. Leverages Corporate Strengths to Impact Real Estate and Lending Industries Through Wholly Owned Subsidiaries REZYFi Lending and ResMac Inc.

While traditional lenders remain reluctant to serve state-licensed cannabis industry prospects, REZYFi focuses on servicing the sectorResMac subsidiary expects to accumulate $285 million in retail origination and $250 million in wholesale origination in 2023The National Association of Realtors(R) reported one-third of surveyed agents experienced an increase in demand for warehouses, 28% in land demand, and 23% in demand for storefront property REZYFi, a cannabis mortgage…

Tuesday Sep 13, 2022 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC), Cannabis Brand Builder, is Ramping Up its HR Productivity and Effectiveness One Appointment at a Time

A 2017 study by McKinsey & Company showed that high performers tend to be 400% more productive than average ones. This outlook has shaped Flora Growth’s hiring strategy for 2022, with the appointment of several key individuals whose proven talents and productivity are seen as critical to the company’s goal of delivering the most compelling customer experiences, most recently with the appointment of Elshad Garayev as…

Monday Sep 12, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Acquires 27th Worldwide Patent Applying to a Range of APIs in Ready-to-Drink Consumer Retail Beverage Products

Lexaria’s Mexican patent “Stable Ready-to-Drink Beverage Compositions Comprising Lipophilic Active Ingredients” joins the ranks of previously issued patents in Australia, India, Japan and the EUThe patent allows the company to provide value in gaining regulatory approval for its DehydraTECH(TM)-enabled CBD for multiple indications in the health and wellness fieldAdditional claims to Mexican patent #390001 include Alzheimer’s disease, Parkinson’s disease, schizophrenia, Human Immunodeficiency Virus (“HIV”) dementia,…

Thursday Sep 08, 2022 - 9:00 am

Flora Growth Corp. (NASDAQ: FLGC) Names New CFO, Process for Ensuring Smooth Transition Amid Company’s Global Growth

Global cannabis brand-builder Flora Growth recently named a former Amazon financial executive as its new CFO Elshad Garayev will work with outgoing CFO Lee Leiderman to ensure a smooth transition of responsibility amid finalization of Flora’s mid-year financial filing with the SECFlora Growth is headquartered in Canada with cultivation operations centered in Colombia, where recent government administrations have opened regulatory processes for exporting cannabis derivatives for…

Tuesday Sep 06, 2022 - 9:45 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Quest to Find Hypertension Treatment Promising With DehydraTECH(TM)’s Ability to Boost Bioavailability

Lexaria, a global innovator of drug delivery platforms is looking to provide a FDA registered hypertension treatment with its patented DehydraTECH technologyThe company’s efforts are encapsulated in its DehydraTECH-CBD that has been shown to lower blood pressure as well as reduce arterial stiffnessAlthough hypertension is a devastating condition that can cause not only life-threatening illnesses but also death, only about 53% of Americans with the…

Wednesday Aug 31, 2022 - 12:15 pm

REZYFi, Inc. Is ‘One to Watch’

REZYFi Lending sees higher margin lending opportunities as well as significant market opportunity to provide the growing and underserved cannabis industry with financial servicesResMac forecasts $285 million in retail loan origination in 2023 and foresees strong growth opportunitiesResMac is on pace to originate $250 million in wholesale loan business in 2023, with its year-over-year credit facility increase expected to jump more than 300%The company’s management…

Tuesday Aug 30, 2022 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces the Availability of a Broadcast titled, “The Power of Science to Stop a Killer”

Lexaria’s latest broadcast highlights the company’s progress in finding a potential solution for hypertension treatment while also pointing out why such a solution is much needed at this pointSince the company began developing its patented DehydraTECH(TM) technology in 2014, it has made significant progress in its clinical studies, even as it currently focuses on human clinical research to evaluate the tolerability, safety, and efficacy of…

Monday Aug 29, 2022 - 9:00 am

AROYA Crop Steering Expertise and Technology Provides Data-Driven Insights, Automation and Competitive Advantage for Successful Harvests

For cannabis operators, crop steering directs how their plants grow as well as their literal shape. Knowing how and when to manipulate light, climate and irrigation – the three foundational components of crop steering – is essential to balancing high yields and high quality. Why do successful growers – from small craft farmers to the largest multistate operators – use data-driven and automated crop steering…

Friday Aug 26, 2022 - 11:15 am

Lexaria Bioscience Corp.’s (NASDAQ: LEXX) Drug Development Program and Recent FDA Confirmation Position It for Favorable Valuation

Lexaria is a global innovator of drug delivery platforms, including its patented DehydraTECH(TM) technologyThe company recently released information that would help its stakeholders research and understand how biotech and pharmaceutical companies are valuedBased on some of the methodologies used in valuation, Lexaria is positioned favorably as its DehydraTECH-processed CBD for the treatment of hypertension has successfully reached the IND application stage, with the program recently…

Friday Aug 19, 2022 - 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Delighted About Well-Received DehydraTECH-CBD Proposals by the FDA; Maintains Late 2022/Early 2023 Target For Complete IND Application

Lexaria’s successful HYPER-H21-2 human clinical study, whose results were announced in the first week of September 2021, laid the groundwork for the company’s patented DehydraTECH(TM)-processed CBD NDAChris Bunka, the company’s CEO, referred to the results as “statistically significant,” ultimately kickstarting the IND application process with the FDALexaria has since received a full written positive response from the FDA on its DehydraTECH-CBD, agreeing to the company’s…

Tuesday Aug 16, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Enters Four Partnerships, Boosts ‘Revenue Picture’

Lexaria Bioscience, a global innovator in drug delivery platforms, recently announced partnerships with Premier Wellness Science Co., BevNology, AnodGen Bioceuticals, and Valcon Medical A/SAccording to coverage by Zacks Small-Cap Research, who value Lexaria at $15 per share, the most impactful of these partnerships is with Premier because the company is expected to start paying license fees in early SeptemberIn a June 7 Fireside Chat, Lexaria…

Friday Aug 12, 2022 - 11:15 am

The New York Cannabis and Hemp Convention to Boost the Growing Local Markets

Businesses, entrepreneurs, advocates, patients, investors, educators, and consumers, are invited to attend the NECANN Convention, a physical event being held in Albany, New York on August 26-27, 2022. NECANN has been producing popular and influential events to local communities throughout the northeast and beyond since 2014, shaping the developing cannabis economy by creating an important hub of resources and communication focused on local markets. NECANN…

Friday Aug 12, 2022 - 9:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Inches Closer to DehydraTECH-CBD FDA Evaluation Following Successful Dosing in Multi-Week HYPER-H21-4 Human Clinical Study

Lexaria just completed dosing for its HYPER H21-4 human clinical study that dosed 64 patients aged between 40 and 70 with measured elevated blood pressure, stage 1 and stage 2 hypertensionHYPER-H21-4, Lexaria’s most ambitious hypertension clinical study yet, builds on the success of HYPER-H21-1 and HYPER-H21-2, both completed in 2021It explores the use of the company’s patented DehydraTECH(TM) technology in the potential treatment of hypertensionLexaria…

Thursday Aug 11, 2022 - 9:00 am

Advanced Container Technologies Inc. (ACTX) Establishing Foothold in Growing Billion-Dollar Vertical Farming Space

Vertical farming projected to reach more than $25 billion by 2030, with a CAGR of 23.3%MRFR report notes that “vertical farming systems and technologies offer a superior approach to farming methods”ACTX GrowPods are essentially vertical micro-farms that can be placed anywhere, allow cultivation of a wide variety of crops, 365 days a year A recent Market Research Future (“MRFR”) report shows that vertical farming is…

Wednesday Aug 10, 2022 - 10:30 am

American Cannabis Partners Has Vested Interest in Cannabis Act Just Passed by U.S. House

MORE Act passed by House, now moves to Senate for considerationBill would “reverse decades of injustices waged on Americans, and especially those from communities of color,” says House Judiciary chairAmerican Cannabis Partners operates in two states, Michigan and California, where cannabis has been legalized The government is making moves once again to remove cannabis from the list of banned controlled substances, with the U.S. House…

Tuesday Aug 09, 2022 - 10:30 am

Advanced Container Technologies Inc. (ACTX) GrowPods May be Part of Solution to Global Food Security

In 2021, a staggering 45 million people were at emergency levels of acute hungerProviding access to food, sustainable food systems are key to WFP’s vision of eradicating food insecurity and malnutritionGrowPods create an optimum controlled environment for growing a wide range of crops in a variety of environments and climates With hunger on the rise again, companies and communities are working together to find realistic…

Monday Jul 25, 2022 - 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Receives Notice of Allowance of 26th Worldwide Patent

Lexaria, a global innovator in drug delivery technology, has developed the patented DehydraTECH(TM) technology which has been the subject of several issued patentsRecently, Lexaria reported it had been notified of the allowance of its 26th worldwide patent with a new patent to be granted in JapanThe patent is the fourth to be granted in Japan and the first patent issued from Lexaria’s seventh patent familyLexaria…

Articles

Articles Category: Cannabis

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions